Cancer researchers tap computers to support preclinical go/no-go decisions

Researchers have developed a computational cancer model to predict how a drug will perform in humans, VentureBeat reports. The in silico system has shown how breast cancer cells develop resistance to drugs, a capability its developers think can influence clinical candidate selection. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.